Associations between three XRCC1 polymorphisms and glioma risk: A meta-analysis

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 3003-3013

  Zhang, Haijun ^a   Liu, Hang ^b   Knauss, Jennifer L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

DNA repair; Glioma; Meta analysis; Polymorphisms; X ray repair cross complementing groups 1; XRCC1

Indexed keywords

ADENINE; ARGININE; GLUTAMINE; GUANINE; HISTIDINE; TRYPTOPHAN; XRCC1 PROTEIN;

ARTICLE; ASIAN; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CODOMINANCE; DOMINANT INHERITANCE; EARLY DIAGNOSIS; GENETIC MODEL; GENOTYPE; GLIOMA; HUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RACE; RECESSIVE INHERITANCE; RISK FACTOR; SUSCEPTIBLE POPULATION; SYSTEMATIC REVIEW; TUMOR GROWTH;

EID: 84885433905     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0865-1     Document Type: Article

References (45)

1. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2004;70(2):217-28.
2. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2(9):494-503. quiz 1 p following 16.
3. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol. 2006;24(8):1273-80.
4. Huncharek M, Muscat J. Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients. Anticancer Res. 1998;18(2B):1303-11.
5. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol. 2004;36(6):1046-69.
6. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21(8):1624-36.
7. Lu AL, Li X, Gu Y, Wright PM, Chang DY. Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys. 2001;35(2):141-70.
8. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1(1):22-33.
9. Aquilina G, Bignami M. Mismatch repair in correction of replication errors and processing of DNA damage. J Cell Physiol. 2001;187(2):145-54.
10. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;27(3):247-54.
11. Ginsberg G, Angle K, Guyton K, Sonawane B. Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat Res. 2011;727(1-2):1-15.
12. Zhang H, Li W, Franklin MJ, Dudek AZ. Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis. Anticancer Res. 2011;31(11):3945-52.
13. Custódio AC, Almeida LO, Pinto GR, Santos MJ, Almeida JRW, Clara CA, et al. Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas. Genet Mol Res. 2011;10(2):1120-9.
14. Felini MJ, Olshan AF, Schroeder JC, North KE, Carozza SE, Kelsey KT, et al. DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology. 2007;29(1-2):55-8.
15. Hu XB, Feng Z, Fan YC, Xiong ZY, Huang QW. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev. 2011;12(11):2981-4.
16. Kiuru A, Lindholm C, Heinavaara S, Ilus T, Jokinen P, Haapasalo H, et al. XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol. 2008;88(2):135-42.
17. Liu HB, Peng YP, Dou CW, Su XL, Gao NK, Tian FM, et al. Comprehensive study on associations between nine SNPs and glioma risk. Asian Pac J Cancer Prev. 2012;13(10):4905-8.
18. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomark Prev. 2009;18(1):204-14.
19. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010;12(1):37-48.
20. Wang D, Hu Y, Gong H, Li J, Ren Y, Li G, et al. Genetic polymorphisms in the DNA repair gene XRCC1 and susceptibility to glioma in a Han population in northeastern China: a case-control study. Gene. 2012;509(2):223-7.
21. Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 2004;64(16):5560-3.
22. Yosunkaya E, Kucukyuruk B, Onaran I, Gurel CB, Uzan M, Kanigur-Sultuybek G. Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg. 2010;24(5):561-5.
23. Zhou LQ, Ma Z, Shi XF, Yin XL, Huang KX, Jiu ZS, et al. Polymorphisms of DNA repair gene XRCC1 and risk of glioma: a case-control study in Southern China. Asian Pac J Cancer Prev. 2011;12(10):2547-50.
24. Cengiz SL, Acar H, Inan Z, Yavuz S, Baysefer A. Deoxy-ribonucleic acid repair genes XRCC1 and XPD polymorphisms and brain tumor risk. Neurosciences (Riyadh). 2008;13(3):227-32.
25. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Aldape K, et al. Constitutive polymorphisms in DNA repair genes ERCC1, ERCC2, XRCC1, and MGMT in adults with glioma and controls. Neuro-Oncology. 2004;6(4):329-30.
26. Liu Y, Shete S, Hosking F, Robertson L, Houlston R, Bondy M. Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev. 2010;20(3):239-44.
27. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomark Prev. 2009;18(4):1118-26.
28. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101-29.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-48.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
31. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101.
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34.
33. R Development Core Team. R: A language and environment for statistical computing. 2010.
34. Jacobs DI, Bracken MB. Association between XRCC1 polymorphism 399 G- > A and glioma among Caucasians: a systematic review and meta-analysis. BMC Med Genet. 2012;13(1):97.
35. Sun JY, Zhang CY, Zhang ZJ, Dong YF, Zhang AL, Wang ZW, et al. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis. Asian Pac J Cancer Prev. 2012;13(9):4783-8.
36. Wei X, Chen D, Lv T. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Mol Biol Rep. 2013;40(1)567-72.
37. Zhang L, Qiu Z, Luo J, Shu W. X-ray repair cross-complementing gene 1 Arg399GIn polymorphism and glioma risk among Asians A meta-analysis based on 2326 cases and 3610 controls. Neural Regen Res. 2012;7(29):2313-9.
38. Zhang L, Wang Y, Qiu Z, Luo J, Zhou Z, Shu W. The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: a meta-analysis involving 1,440 cases and 2,562 controls. Exp Ther Med. 2012;4(6):1057-62.
39. Gu J, Liu Y, Kyritsis AP, Bondy ML. Molecular epidemiology of primary brain tumors. Neurotherapeutics. 2009;6(3):427-35.
40. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012;131(12):1877-88.
41. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899-904.
42. Li WJ, Gu YY, Zhang HJ, Zhou J, Jia HT. Induction of p14ARF by E2F1 contributes to 8-chloro-adenosine-induced apoptosis in human lung cancer H1299 cells. Chemotherapy. 2009;55(5):335-43.
43. Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, Jensen ED, et al. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res. 2011;71(9):3257-67.
44. Zhang HJ, Li WJ, Gu YY, Li SY, An GS, Ni JH, et al. p14ARF interacts with E2F factors to form p14ARF-E2F/partner-DNA complexes repressing E2F-dependent transcription. J Cell Biochem. 2010;109(4):693-701.
45. Zhang HJ, Li WJ, Yang SY, Li SY, Ni JH, Jia HT. 8-Chloro-adenosine- induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites. J Cell Biochem. 2009;106(3):464-72.